Aurobindo Pharma completes acquisition of balance 49% stake of GLS Pharma

28 Oct 2024 Evaluate

Aurobindo Pharma has completed acquisition of balance 49% of equity shares of GLS Pharma. Earlier, the company had entered into a binding agreement on September 18, 2024, with GLS Pharma, a subsidiary of the Company and its promoters for acquisition of balance 5,90,361 equity shares of Rs 10 each (49% of GLS Pharma) for a purchase consideration of Rs 22.5 crore.

The aforementioned acquisition has been completed on October 25, 2024 and GLS has become a wholly owned subsidiary of the company.

Aurobindo Pharma is engaged in manufacturing pharmaceutical products. It offers active pharmaceutical ingredients, intermediates and generic formulations like astemizole, domeperidone and omeprazole; anti-infective, oral and sterile antibiotics, pain management and osteoporosis segments.


Aurobindo Pharma Share Price

1172.30 -7.95 (-0.67%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×